David P. Schenkein

2015

In 2015, David P. Schenkein earned a total compensation of $10.1M as President and Chief Executive Officer at Agios Pharmaceuticals, a 132% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$295,000
Option Awards$9,290,670
Salary$517,500
Other$10,052
Total$10,113,222

Schenkein received $9.3M in option awards, accounting for 92% of the total pay in 2015.

Schenkein also received $295K in non-equity incentive plan, $517.5K in salary and $10.1K in other compensation.

Rankings

In 2015, David P. Schenkein's compensation ranked 494th out of 13,638 executives tracked by ExecPay. In other words, Schenkein earned more than 96.4% of executives.

ClassificationRankingPercentile
All
494
out of 13,638
96th
Division
Manufacturing
166
out of 5,190
97th
Major group
Chemicals And Allied Products
66
out of 1,854
96th
Industry group
Drugs
52
out of 1,528
97th
Industry
Pharmaceutical Preparations
41
out of 1,182
97th
Source: SEC filing on April 18, 2018.

Schenkein's colleagues

We found four more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2015.

2015

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2015

J Higgons

Agios Pharmaceuticals

Chief Operating Officer

2015

Glenn Goddard

Agios Pharmaceuticals

Former Sr. Vice President, Finance

2015

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like